AbbVie Scholarship

Eligibility Criteria

• Are enrolled in the First or Second Year of the full-time Pharmaceutical Engineering undergraduate degree programme offered by the Institute;

• Have achieved outstanding academic results as the Institute may in its sole discretion determine;

• Have leadership qualities as the Institute may in its sole discretion determine; and

• Have made significant contributions beyond academic studies to the Institute or the community as determined by the Institute in its sole discretion.

• Preference for at least one female recipient.

• Applicable across all nationalities.

Benefits & Obligation of Scholarship:

• Each scholarship is valued at S$7,500 and is applicable for one academic year.

• The Scholarship shall be used for the recipient’s educational expenses such as tuition fees, course materials, expenses for any overseas immersion programmes conducted by the Institute, and fees for other educational activities organised by the Institute.

• Recipients who have already been awarded the Scholarship for one year of study may apply to receive and be considered for the Scholarship in a subsequent year of study, subject to the fulfilment of the above selection criteria, and with the recommendation of the Institute and the selection by the Selection Committee.

• The recipients may accept other scholarships, bursaries, grants or awards concurrently.

About the Donor

AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people’s lives. The company’s commitment is measured by the impact they make – to patients, to the communities, and to the world. AbbVie’s 50,000 employees strive to make a remarkable impact that lasts, driven by their compassion for people, commitment to innovation and inclusion, service to the community and uncompromising integrity. Today, AbbVie’s products help more than 62 million people living in more than 175 countries, and we are making significant advancements with a robust pipeline of potential new medicines as they look to find the treatments of tomorrow.